HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Stephen E Moss Selected Research

pervanadate

6/2009Annexin A2 at the interface between F-actin and membranes enriched in phosphatidylinositol 4,5,-bisphosphate.
4/2004Annexin 2 binding to phosphatidylinositol 4,5-bisphosphate on endocytic vesicles is regulated by the stress response pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Stephen E Moss Research Topics

Disease

9Neoplasms (Cancer)
06/2022 - 10/2004
7Macular Degeneration (Age-Related Maculopathy)
08/2021 - 10/2007
4Retinal Diseases
04/2015 - 10/2007
3Glaucoma
08/2007 - 01/2005
2Choroidal Neovascularization
06/2022 - 01/2012
2Blindness (Hysterical Blindness)
01/2022 - 10/2007
2Cataract (Cataracts)
08/2021 - 01/2011
2Osteoarthritis
01/2018 - 11/2012
2Necrosis
01/2015 - 01/2011
2Oculocerebrorenal Syndrome (Lowe Syndrome)
01/2011 - 06/2009
2Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
01/2010 - 04/2002
2Shock
06/2009 - 04/2004
1Inflammation (Inflammations)
01/2022
1Choroid Diseases
01/2022
1Vision Disorders (Hemeralopia)
01/2022
1Fibrosis (Cirrhosis)
01/2022
1COVID-19
01/2022
1Neoplasm Metastasis (Metastasis)
09/2021
1Hypoglycemia (Reactive Hypoglycemia)
12/2020
1Wounds and Injuries (Trauma)
11/2020
1Pain (Aches)
01/2018
1Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
01/2017
1Brain Neoplasms (Brain Tumor)
01/2016
1Vascular Diseases (Vascular Disease)
04/2014
1Renal Insufficiency (Renal Failure)
01/2011
1Intellectual Disability (Idiocy)
01/2011
1Hypertension (High Blood Pressure)
12/2010
1Retinal Dystrophies
01/2010
1Sarcoidosis (Schaumann Disease)
01/2009
1Ganglion Cysts (Ganglion)
06/2008
1Prostatic Neoplasms (Prostate Cancer)
05/2008
1Complement Factor H Deficiency
10/2007
1Alzheimer Disease (Alzheimer's Disease)
08/2007
1Ocular Hypertension (Glaucoma, Suspect)
02/2006
1Cardiovascular Diseases (Cardiovascular Disease)
10/2004
1Leukemia
04/2004
1Acute Promyelocytic Leukemia
04/2002
1Heart Failure
04/2002

Drug/Important Bio-Agent (IBA)

8AnnexinsIBA
01/2017 - 04/2002
6Retinaldehyde (Retinal)IBA
01/2022 - 10/2007
6Proteins (Proteins, Gene)FDA Link
11/2021 - 04/2004
5Leucine (L-Leucine)FDA Link
06/2022 - 07/2013
3Complement System Proteins (Complement)IBA
10/2015 - 01/2015
2Glycoproteins (Glycoprotein)IBA
01/2022 - 11/2020
2Annexin A6IBA
01/2018 - 11/2012
2Retinal Pigments (Pigments, Visual)IBA
10/2015 - 01/2015
2Annexin A5IBA
11/2012 - 01/2011
2pervanadateIBA
06/2009 - 04/2004
1Interleukin-6 (Interleukin 6)IBA
01/2022
1AntigensIBA
09/2021
1STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
09/2021
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2021
1Glucose (Dextrose)FDA LinkGeneric
12/2020
1Alanine (L-Alanine)FDA Link
12/2020
1Complement Factor B (Factor B)IBA
11/2020
1Conotoxins (Conotoxin)IBA
01/2018
1podocalyxinIBA
01/2016
1Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
01/2015
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
01/2015
1Vascular Endothelial Growth FactorsIBA
04/2014
1CollagenIBA
11/2012
1VLDL LipoproteinsIBA
01/2012
1Inositol Polyphosphate 5-PhosphatasesIBA
01/2011
1PhosphatidylserinesIBA
01/2011
1Macular PigmentIBA
12/2010
1Annexin A2 (Annexin II)IBA
06/2009
1CalciumIBA
01/2009
1IonomycinIBA
01/2009
1Arginine (L-Arginine)FDA Link
01/2009
1Cysteine (L-Cysteine)FDA Link
01/2009
1CalpainIBA
05/2008
1Membrane Proteins (Integral Membrane Proteins)IBA
05/2008
1Interferon-gamma (Interferon, gamma)IBA
05/2008
1Complement Factor H (Factor H)IBA
10/2007
1Amyloid beta-PeptidesIBA
08/2007
1Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA
02/2006
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
02/2006
1Dizocilpine Maleate (Dizocilpine)IBA
02/2006
1eglumetadIBA
02/2006
1Neuroprotective AgentsIBA
02/2006
1Glutamic Acid (Glutamate)FDA Link
02/2006
1ifenprodilIBA
02/2006
1Laminin (Merosin)IBA
01/2005
1Phorbol EstersIBA
04/2004
1AntibodiesIBA
04/2004

Therapy/Procedure

5Therapeutics
11/2021 - 02/2006
1Intravitreal Injections
08/2021
1Transplantation
01/2016
1Lasers (Laser)
01/2012